Virax raises $3m for Pathway takeover

25/03/2014 - 12:10

Bookmark

Save articles for future reference.

Virax Holdings has completed a $3 million equity placement to sophisticated investors to support its acquisition last week of Pathway Oncology.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options